HD-OPM Archive
Hashtags

#cardiology

33 posts

Lipoprotein(a) explained: 80-90% genetic, stable for life, a risk factor beyond LDL

Oct 05, 2024 · Gokhan Can ♥ 12 · 💬 8 Lp(a)

Explainer on Lp(a): an LDL-like particle with apo(a) attached, 80-90% genetically determined, fully expressed by 1-2 years of age, and elevated in about 1 in 5 US individuals (1.4 billion globally). Levels above 50 mg/dL or 125 nmol/L raise ASCVD risk, possibly via impaired fibrinolysis and cholesterol deposition, and may occur with normal lipid panels.

Pelacarsen and ziltivekimab lowered their targets but not events, and why that matters

Nov 08, 2026 · Louis Nervegna ♥ 8 · 💬 6 Lp(a)

Louis shares a physician's commentary on the Lp(a) and inflammation trials presented at AHA: one drug lowered Lp(a) nearly 80% and another sharply cut inflammation, yet event rates matched placebo. The lesson is that measuring and changing a marker does not guarantee benefit, and that the underlying risk factors still matter.

REACT: silent atherosclerosis found in 57% of 16,808 adults, 7-9% of 18-29-year-olds

Sep 26, 2026 · Louis Nervegna ♥ 11 · 💬 2 Plaque, CAC & CT angiography

The NEJM REACT study used carotid and femoral ultrasound plus coronary CT angiography in 16,808 adults aged 18-70 without known disease. Plaque was present in 57% overall, appeared in young adults, and a zero calcium score often missed early non-calcified plaque. Ten-year risk scores detected very little silent disease, so keeping risk factors favorable throughout life is the priority.

Lepodisiran siRNA cut Lp(a) by 93.9% at 400 mg in a 320-person NEJM trial

May 07, 2025 · Louis Nervegna ♥ 15 · 💬 1 Lp(a)

Luigi Fontana's summary of an NEJM trial of lepodisiran, an siRNA that blocks hepatic Lp(a) production. At the 400 mg dose Lp(a) fell by 93.9% placebo-adjusted, lasting up to a year, with only mild injection-site reactions. It offers a potential option for people with genetically high Lp(a) who cannot lower it with lifestyle or standard drugs.

VO2 max is a ratio, and chasing it can mislead about heart health

Jul 19, 2026 · Louis Nervegna ♥ 13 · 💬 1 Exercise & fitness

Louis agrees with a critique of influencers who treat VO2 max as the key heart-health metric. VO2 max is oxygen consumption divided by body weight, so it can rise through weight loss without real fitness gain. He also notes AHA and ACC statements recognizing high-volume intense exercise can have downsides.

2026 ACC Scientific Statement: overall dietary pattern matters most for heart disease

Oct 01, 2026 · Louis Nervegna ♥ 11 Mediterranean, DASH, MIND & plant-forward diets

A new American College of Cardiology scientific statement reviews nutrition for preventing and managing cardiovascular disease and stresses overall diet quality over single nutrients. It supports replacing saturated fat with unsaturated fat, more fiber and whole grains, and less sodium, ultra-processed food and sugary drinks. The poster notes it closely matches the group's recommended diet.

North Karelia: swapping butter for vegetable oils credited with 80%+ fewer coronary deaths

Louis says replacing saturated with unsaturated fat is believed to be a main reason heart deaths dropped in Finland in the 1970s and 1980s. The shared cardiologist's post describes North Karelia's 700 per 100,000 CVD death rate in 1972, with 24% of calories from saturated fat, and a 20% cholesterol drop with coronary deaths in working-age men falling 82%.